OGDH — Oxoglutarate Dehydrogenase

OGDH — Oxoglutarate Dehydrogenase

Overview

OGDH (Oxoglutarate Dehydrogenase) encodes the E1 subunit (alpha-ketoglutarate dehydrogenase) of the alpha-ketoglutarate dehydrogenase complex (α-KGDH), a key mitochondrial enzyme in the tricarboxylic acid (TCA) cycle. Located on chromosome 7p13, OGDH catalyzes the oxidative decarboxylation of α-ketoglutarate to succinyl-CoA, producing NADH and CO2. This reaction is the second NADH-producing step in the TCA cycle and is essential for cellular energy metabolism.

<div class="infobox infobox-gene">

| Property | Value |
|----------|-------|
| Gene Symbol | OGDH |
| Full Name | Oxoglutarate Dehydrogenase |
| Chromosomal Location | 7p13 |
| NCBI Gene ID | 4967 |
| OMIM ID | 203740 |
| Ensembl ID | ENSG00000105953 |
| UniProt ID | Q02218 |
| Encoded Protein | OGDH (α-KGDH E1) |
| Gene Type | Protein-coding |
| Protein Family | 2-oxoacid dehydrogenase family |
| Associated Diseases | Alzheimer's disease, Parkinson's disease, 2-hydroxyglutaric aciduria |

</div>

OGDH is a critical metabolic enzyme whose activity is significantly reduced in aging brain and in neurodegenerative diseases including Alzheimer's disease (AD) and Parkinson's disease (PD). The enzyme is particularly vulnerable to oxidative stress, creating a feed-forward cycle of mitochondrial dysfunction in neurodegeneration.

Structure and Function

Protein Structure

OGDH is the E1alpha subunit of the α-KGDH complex [@hubbs2012]:

OGDH — Oxoglutarate Dehydrogenase

Overview

OGDH (Oxoglutarate Dehydrogenase) encodes the E1 subunit (alpha-ketoglutarate dehydrogenase) of the alpha-ketoglutarate dehydrogenase complex (α-KGDH), a key mitochondrial enzyme in the tricarboxylic acid (TCA) cycle. Located on chromosome 7p13, OGDH catalyzes the oxidative decarboxylation of α-ketoglutarate to succinyl-CoA, producing NADH and CO2. This reaction is the second NADH-producing step in the TCA cycle and is essential for cellular energy metabolism.

<div class="infobox infobox-gene">

| Property | Value |
|----------|-------|
| Gene Symbol | OGDH |
| Full Name | Oxoglutarate Dehydrogenase |
| Chromosomal Location | 7p13 |
| NCBI Gene ID | 4967 |
| OMIM ID | 203740 |
| Ensembl ID | ENSG00000105953 |
| UniProt ID | Q02218 |
| Encoded Protein | OGDH (α-KGDH E1) |
| Gene Type | Protein-coding |
| Protein Family | 2-oxoacid dehydrogenase family |
| Associated Diseases | Alzheimer's disease, Parkinson's disease, 2-hydroxyglutaric aciduria |

</div>

OGDH is a critical metabolic enzyme whose activity is significantly reduced in aging brain and in neurodegenerative diseases including Alzheimer's disease (AD) and Parkinson's disease (PD). The enzyme is particularly vulnerable to oxidative stress, creating a feed-forward cycle of mitochondrial dysfunction in neurodegeneration.

Structure and Function

Protein Structure

OGDH is the E1alpha subunit of the α-KGDH complex [@hubbs2012]:

The enzyme requires thiamine pyrophosphate (TPP) as an essential cofactor, coordinating at the active site with Mg2+ and participating in decarboxylation.

Alpha-KGDH Complex

The α-KGDH complex is a multienzyme assembly:

| Subunit | Gene | Function |
|--------|------|----------|
| E1α | OGDH | Oxidative decarboxylation |
| E1β | OGDHL1 | Dihydrolipoyl dehydrogenase |
| E2 | DLST | Dihydrolipoamide succinyltransferase |
| E3 | DLD | Lipoamide dehydrogenase |

Catalytic Mechanism

The reaction catalyzed by α-KGDH:

α-ketoglutarate + CoA + NAD+ → succinyl-CoA + NADH + CO2

This reaction:

• Produces one NADH per cycle
• Releases CO2 (decarboxylation)
• Generates succinyl-CoA for the TCA cycle

Role in TCA Cycle

Metabolic Position

α-KGDH occupies a critical position in the TCA cycle [@tretter2016]:

Importance in Neurons

In neurons, α-KGDH serves additional functions [@lin2020]:

• Neurotransmitter synthesis: Succinyl-CoA is a precursor for heme synthesis
• Energy production: High demand in neurons
• Metabolic flexibility: Links to amino acid metabolism

Regulation

The enzyme is tightly regulated:

| Regulator | Effect | Mechanism |
|-----------|--------|-----------|
| NADH/NAD+ ratio | Inhibition | Product inhibition |
| ATP | Inhibition | Energy sensing |
| Succinyl-CoA | Inhibition | Product inhibition |
| ROS | Inhibition | Oxidative damage |
| Thiamine | Protection | Cofactor availability |

Role in Neurodegeneration

Alzheimer's Disease

OGDH activity is significantly reduced in AD brain [@shi2019] [@bubber2005]:

Reduced activity in AD:

• 40-70% reduction in AD frontal cortex
• 30-50% reduction in AD hippocampus
• Correlation with disease severity
• One of the earliest metabolic defects

• Oxidative inactivation
• Post-translational modifications
• Reduced protein levels
• TPP cofactor deficiency

Parkinson's Disease

OGDH deficiency in PD [@gibson2015]:

• Reduced activity in substantia nigra
• Vulnerable dopaminergic neurons
• Link to mitochondrial complex I defects

• High energy demand
• Particular oxidative stress
• Limited antioxidant capacity

Mechanistic Framework

Molecular Mechanisms

Oxidative Stress Response

α-KGDH is highly sensitive to oxidative stress [@bunik2018]:

• Contains critical cysteine residues
• TPP cofactor oxidation
• Irreversible inactivation by ROS

Metabolomic Consequences

Reduced α-KGDH leads to:

• α-ketoglutarate accumulation
• NADH/NAD+ ratio changes
• Succinyl-CoA deficiency
• Heme synthesis impairment

Interplay with Other Enzymes

The enzyme interacts with:

| Enzyme | Interaction | Consequence |
|--------|-------------|-------------|
| Complex I | Sequential NADH production | Combined deficiency |
| PDH | Parallel pathway | Metabolic shunting |
| IDH | α-ketoglutarate pool | Feedback regulation |

Disease Association

2-Hydroxyglutaric Aciduria

OGDH mutations cause 2-hydroxyglutaric aciduria [@zhang2012]:

• 2R-2HG accumulation: Elevated R-2-hydroxyglutarate
• Neurological symptoms: Developmental delay, seizures
• MRI abnormalities: Basal ganglia involvement

Cancer Metabolism

OGDH acts as a tumor suppressor in cancer [@cooper2012]:

• Diverts carbon from anabolism
• Limits glutamine utilization
• Metabolic tumor suppressor

Therapeutic Implications

Targeting α-KGDH

Therapeutic approaches:

• Supports cofactor levels
• Shown to improve cognition in some trials
• Safe and accessible

• Protect enzyme from oxidation
• Mitochondria-targeted antioxidants
• N-acetylcysteine

• Increase α-KGDH expression
• Reduce product inhibition
• Mitochondrial biogenesis

• AAV-mediated delivery
• Requires optimization

Challenges

Expression Patterns

Brain Regional Distribution

| Brain Region | Expression Level | Significance |
|--------------|------------------|--------------|
| Cortex | High | High metabolic demand |
| Hippocampus | High | Memory circuits |
| Substantia nigra | Moderate | Dopaminergic neurons |
| Cerebellum | Moderate | Motor coordination |

Cellular Expression

• Neurons: High expression (high energy demand)
• Astrocytes: Lower expression
• Oligodendrocytes: Variable

Age-Related Changes

• Activity declines with normal aging
• More severe decline in AD/PD
• Precedes clinical symptoms

Key Interactions Table

| Protein/Pathway | Interaction Type | Relevance |
|-----------------|------------------|-----------|
| DLST | Complex assembly | E2 subunit |
| DLD | Complex assembly | E3 subunit |
| Complex I | Sequential | ETC function |
| PDH | Parallel | TCA regulation |
| IDH | Substrate shared | α-KG pool |
| Thiamine | Cofactor | Enzymatic activity |

Research Tools

Detection Methods

• Enzyme activity assays: Measure α-KGDH activity
• Western blot: Protein levels
• Immunohistochemistry: Localization
• Metabolomics: Substrate/product ratios

Experimental Models

• Knockout mice: Lethal (embryonic)
• Conditional knockouts: Tissue-specific
• Patient iPSCs: Disease modeling

See Also

• [TCA Cycle](/mechanisms/tricarboxylic-acid-cycle)
• [Mitochondrial Metabolism](/mechanisms/mitochondrial-metabolism)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Energy Metabolism](/mechanisms/energy-metabolism)
• [Oxidative Stress](/mechanisms/oxidative-stress)

External Links

• [Ensembl: ENSG00000105953](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000105953)
• [NCBI Gene: OGDH](https://www.ncbi.nlm.nih.gov/gene/4967)
• [GeneCards: OGDH](https://www.genecards.org/cgi-bin/carddisp.pl?gene=OGDH)
• [OMIM: OGDH](https://omim.org/entry/203740)
• [UniProt: Q02218](https://www.uniprot.org/uniprot/Q02218)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving OGDH — Oxoglutarate Dehydrogenase discovered through SciDEX knowledge graph analysis: